Jade Biosciences Ord Shs
JBIO15.435USD
+0.455+3.04%
Market hours （ET）Quotes delayed by 15 min
503.60MMarket Cap
LossP/E TTM
More Details of Company
Jade Biosciences Ord Shs Info
Ticker Symbol- -
Company name- -
IPO date- -
CEO- -
Number of employees- -
Security type- -
Fiscal year-end- -
Address- -
City- -
Stock exchange- -
Country- -
Postal code- -
Phone- -
Website- -
Ticker Symbol- -
IPO date- -
CEO- -
Company Executives of Jade Biosciences Ord Shs
Name
Name/Position
Position
Shareholding
Change
Dr. Benjamin T. Dake, Ph.D.
Dr. Benjamin T. Dake, Ph.D.
President, Chief Operating Officer, Secretary
President, Chief Operating Officer, Secretary
505.00
+9.31%
Mr. Habib Joseph Dable
Mr. Habib Joseph Dable
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Bradford D. (Brad) Dahms
Mr. Bradford D. (Brad) Dahms
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
--
--
Dr. Ralph Niven, Ph.D.
Dr. Ralph Niven, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
Mr. Stephen K. Yu
Mr. Stephen K. Yu
Senior Vice President - Quality
Senior Vice President - Quality
--
--
Dr. Joshua Resnick, M.D.
Dr. Joshua Resnick, M.D.
Independent Director
Independent Director
--
--
Dr. Marinus Verwijs, Ph.D.
Dr. Marinus Verwijs, Ph.D.
Chief Technical Officer
Chief Technical Officer
--
--
Dr. David S. Grayzel, M.D.
Dr. David S. Grayzel, M.D.
Independent Director
Independent Director
--
--
Ms. Allison Dorval, CPA
Ms. Allison Dorval, CPA
Independent Director
Independent Director
--
--
Mrs. Susan Fischer
Mrs. Susan Fischer
Executive Vice President - Development Operations
Executive Vice President - Development Operations
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Benjamin T. Dake, Ph.D.
Dr. Benjamin T. Dake, Ph.D.
President, Chief Operating Officer, Secretary
President, Chief Operating Officer, Secretary
505.00
+9.31%
Mr. Habib Joseph Dable
Mr. Habib Joseph Dable
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Bradford D. (Brad) Dahms
Mr. Bradford D. (Brad) Dahms
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
--
--
Dr. Ralph Niven, Ph.D.
Dr. Ralph Niven, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
Mr. Stephen K. Yu
Mr. Stephen K. Yu
Senior Vice President - Quality
Senior Vice President - Quality
--
--
Dr. Joshua Resnick, M.D.
Dr. Joshua Resnick, M.D.
Independent Director
Independent Director
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Wed, Dec 10
Updated: Wed, Dec 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Fidelity Management & Research Company LLC
10.41%
Fairmount Funds Management LLC
9.90%
VR Adviser, LLC
7.00%
RA Capital Management, LP
6.99%
Janus Henderson Investors
6.66%
Other
59.04%
Shareholders
Shareholders
Proportion
Fidelity Management & Research Company LLC
10.41%
Fairmount Funds Management LLC
9.90%
VR Adviser, LLC
7.00%
RA Capital Management, LP
6.99%
Janus Henderson Investors
6.66%
Other
59.04%
Shareholder Types
Shareholders
Proportion
Hedge Fund
22.92%
Venture Capital
20.14%
Investment Advisor
19.66%
Investment Advisor/Hedge Fund
16.63%
Private Equity
4.23%
Individual Investor
0.95%
Research Firm
0.50%
Bank and Trust
0.08%
Pension Fund
0.02%
Other
14.86%
Institutional Shareholding
Updated: Tue, Dec 9
Updated: Tue, Dec 9
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
215
38.72M
84.16%
+6.13M
2025Q3
219
31.65M
77.53%
-1.17M
2025Q2
222
32.33M
102.43%
+21.99M
2025Q1
207
926.72K
111.95%
-347.50K
2024Q4
207
879.69K
106.31%
-203.28K
2024Q3
202
808.07K
98.05%
-248.23K
2024Q2
199
794.81K
96.63%
-106.00K
2024Q1
171
831.84K
104.51%
-50.52K
2023Q4
165
824.02K
104.24%
-56.42K
2023Q3
162
814.98K
103.17%
-89.07K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Fidelity Management & Research Company LLC
4.79M
10.41%
+53.40K
+1.13%
Sep 30, 2025
Fairmount Funds Management LLC
3.22M
9.87%
--
--
Sep 30, 2025
VR Adviser, LLC
3.22M
9.87%
--
--
Sep 30, 2025
RA Capital Management, LP
1.06M
3.26%
--
--
Sep 30, 2025
Deep Track Capital LP
2.28M
6.99%
-229.41K
-9.14%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
1.96M
4.26%
+401.34K
+25.73%
Sep 30, 2025
The Vanguard Group, Inc.
1.73M
3.75%
-80.84K
-4.47%
Sep 30, 2025
Versant Ventures
1.53M
3.32%
--
--
Sep 30, 2025
RTW Investments L.P.
1.45M
3.15%
--
--
Sep 30, 2025
View more
Related ETFs
Updated: Tue, Dec 9
Updated: Tue, Dec 9
Name
Proportion
iShares Micro-Cap ETF
0.08%
iShares Russell 2000 Value ETF
0.03%
Global X Russell 2000 ETF
0.02%
Invesco Russell 2000 Dynamic Multifactor ETF
0.02%
ProShares Hedge Replication ETF
0.02%
ProShares UltraPro Russell2000
0.01%
Proshares Ultra Russell 2000
0.01%
iShares Russell 2000 ETF
0.01%
iShares Russell 3000 ETF
0%
iShares Russell 2000 Growth ETF
0%
View more
iShares Micro-Cap ETF
Proportion0.08%
iShares Russell 2000 Value ETF
Proportion0.03%
Global X Russell 2000 ETF
Proportion0.02%
Invesco Russell 2000 Dynamic Multifactor ETF
Proportion0.02%
ProShares Hedge Replication ETF
Proportion0.02%
ProShares UltraPro Russell2000
Proportion0.01%
Proshares Ultra Russell 2000
Proportion0.01%
iShares Russell 2000 ETF
Proportion0.01%
iShares Russell 3000 ETF
Proportion0%
iShares Russell 2000 Growth ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Apr 21, 2025
Merger
35→1
Date
Type
Ratio
Apr 21, 2025
Merger
35→1
FAQs
Who are the top five shareholders of Jade Biosciences Ord Shs?
The top five shareholders of Jade Biosciences Ord Shs are:
Fidelity Management & Research Company LLC holds 4.79M shares, accounting for 10.41% of the total shares.
Fairmount Funds Management LLC holds 3.22M shares, accounting for 9.87% of the total shares.
VR Adviser, LLC holds 3.22M shares, accounting for 9.87% of the total shares.
RA Capital Management, LP holds 1.06M shares, accounting for 3.26% of the total shares.
Deep Track Capital LP holds 2.28M shares, accounting for 6.99% of the total shares.
Fidelity Management & Research Company LLC holds 4.79M shares, accounting for 10.41% of the total shares.
Fairmount Funds Management LLC holds 3.22M shares, accounting for 9.87% of the total shares.
VR Adviser, LLC holds 3.22M shares, accounting for 9.87% of the total shares.
RA Capital Management, LP holds 1.06M shares, accounting for 3.26% of the total shares.
Deep Track Capital LP holds 2.28M shares, accounting for 6.99% of the total shares.
What are the top three shareholder types of Jade Biosciences Ord Shs?
The top three shareholder types of Jade Biosciences Ord Shs are:
Fidelity Management & Research Company LLC
Fairmount Funds Management LLC
VR Adviser, LLC
Fidelity Management & Research Company LLC
Fairmount Funds Management LLC
VR Adviser, LLC
How many institutions hold shares of Jade Biosciences Ord Shs (JBIO)?
As of 2025Q4, 215 institutions hold shares of Jade Biosciences Ord Shs, with a combined market value of approximately 38.72M, accounting for 84.16% of the total shares. Compared to 2025Q3, institutional shareholding has increased by 6.63%.
What is the biggest source of revenue for Jade Biosciences Ord Shs?
In --, the -- business generated the highest revenue for Jade Biosciences Ord Shs, amounting to -- and accounting for --% of total revenue.
